Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ALZN is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
2 top institutions tracked
Sentiment: neutral
Last trade: sell 45 days ago
Red flags: 13
12 filers reported a long position in ALZN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Kingsbury Capital Investment Advisors LLC | $1.6M | 1.3M | +134.5% |
| KMT WEALTH MANAGEMENT, LLC | $1.6M | 1.3M | New |
| GEODE CAPITAL MANAGEMENT, LLC | $31.6K | 26.4K | -42.3% |
| VANGUARD FIDUCIARY TRUST CO | $25.2K | 21K | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.1K | 7.6K | +71.7% |
| Tower Research Capital LLC (TRC) | $4.2K | 3.5K | -43.1% |
| UBS Group AG | $2.8K | 2.4K | -47.8% |
| BlackRock, Inc. | $524 | 437 | Unchanged |
| IFG Advisory, LLC | $26 | 22 | New |
| SBI Securities Co., Ltd. | $26 | 22 | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.